
Danish pharma giant buys San Diego company’s epilepsy drug for $2.6B
Lundbeck, a global drugmaker based in Denmark, has agreed to buy La Jolla-based Longboard Pharmaceuticals for $2.6 billion to gain access to its novel epilepsy drug. The acquisition announced Monday will expand Lundbeck’s existing portfolio of treatments …